Sunday, 17 October 2021


Lupin launches generic Benicar tablets in the US

04 September 2017 | News

The tablets, 5 mg, 20 mg and 40 mg are the AB rated generic equivalent of Daiichi Sankyo Inc.’s Benicar tablets

Source: Pixabay

Source: Pixabay

Pharma company Lupin Limited has announced the launch of its Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg having received an approval from the United States Food and Drug Administration (FDA) earlier.

The tablets, 5 mg, 20 mg and 40 mg are the AB rated generic equivalent of Daiichi Sankyo Inc.’s Benicar tablets and indicated for the treatment of hypertension, alone or in combination with other antihypertensive agents, to lower blood pressure.

Benicar tablets had US sales of USD 681 million (IMS MAT July 2017).

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account